Authors: Brenu, Ekua W.; Atkinson, Gunn M.; Driel, Mieke L. van; Kreijkamp-Kaspers, Sanne; Staines, Don R.; Marshall-Gradisnik, Sonya M.
International Journal of Clinical Medicine, 2013
View article | Discussion on S4ME
Main findings: "GZMB was significantly increased overall in the CFS/ME patients compared to the controls. GZMA was significantly increased 28 days after vaccination while PRF1 was reduced prevaccination but increased 14 days post-vaccination in the CFS/ME patients."